Page last updated: 2024-09-02

ecteinascidin 743 and bilirubin

ecteinascidin 743 has been researched along with bilirubin in 1 studies

Compound Research Comparison

Studies
(ecteinascidin 743)
Trials
(ecteinascidin 743)
Recent Studies (post-2010)
(ecteinascidin 743)
Studies
(bilirubin)
Trials
(bilirubin)
Recent Studies (post-2010) (bilirubin)
66010240425,9211,3375,871

Protein Interaction Comparison

ProteinTaxonomyecteinascidin 743 (IC50)bilirubin (IC50)
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)3.3884
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.3183

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davies, R; Dinsdale, D; Donald, S; Edwards, R; Gant, TW; Gescher, AJ; Greaves, P; Judah, DJ; Lopez Lazaro, L; Riley, J; Smith, AG; Verschoyle, RD1

Other Studies

1 other study(ies) available for ecteinascidin 743 and bilirubin

ArticleYear
Hepatobiliary damage and changes in hepatic gene expression caused by the antitumor drug ecteinascidin-743 (ET-743) in the female rat.
    Cancer research, 2002, Aug-01, Volume: 62, Issue:15

    Topics: Animals; Antineoplastic Agents, Alkylating; Bile Duct Diseases; Bilirubin; Cell Division; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Dioxoles; Female; Gene Expression; Isoquinolines; Liver; Liver Diseases; Rats; Rats, Wistar; Tetrahydroisoquinolines; Trabectedin

2002